Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
42.7M
-
Shares change
-
+192K
-
Total reported value, excl. options
-
$1.44B
-
Value change
-
+$13.2M
-
Put/Call ratio
-
0.78
-
Number of buys
-
100
-
Number of sells
-
-64
-
Price
-
$33.73
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q2 2018
209 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q2 2018.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.7M shares
of 79.2M outstanding shares and own 53.84% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.07M shares), BlackRock Inc. (3.45M shares), VANGUARD GROUP INC (3.2M shares), STATE STREET CORP (2.52M shares), D. E. Shaw & Co., Inc. (2.39M shares), SCOPIA CAPITAL MANAGEMENT LP (2.3M shares), venBio Select Advisor LLC (2.29M shares), BOXER CAPITAL, LLC (1.9M shares), Marshall Wace North America L.P. (1.71M shares), and GREAT POINT PARTNERS LLC (1.57M shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.